Track record · closed signal

Halozyme Therapeutics, Inc. (HALO) — closed signal from March 4, 2026

Partial Published before the outcome was known, scored automatically when the window closed on June 2, 2026 — -6.7% at the close.

Predicted vs. what happened

HALO price · publication thesis → realized outcomesplit-adjusted

$68.50 – $71.50Entry zone — fair-value band

$71.06Published — price the day we called it

$83.84Target — the price the thesis aimed for

$73.89Peak — highest point inside the window, not a realized return

$66.28Window close — end-of-window price, context only

What happened

Partial

Reached 22% of the predicted growth at its peak, without hitting the target.

At window close

-6.7%

realized, from the publication price to the last close inside the window

Peak gain

+4%

peak, from the publication price — not a realized return

S&P 500, same window

+11.2%

SPY over the identical days, dividend-adjusted

Window close

$66.28

last close inside the window, ended June 2, 2026

Peak price

$73.89

peak on May 12, 2026 — not a realized return

Days to target

—

The thesis — published March 4, 2026

Predicted growth

+18%

over the measurement window

Target price

$83.84

the price the thesis aimed for

Entry zone

$68.50 – $71.50

the fair-value band we waited for

Price at publication

$71.06

published March 4, 2026

Confidence

82%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

The stock dropped quickly, which can set up a bounce if selling calms. Positive analyst notes and being included in ETFs can draw buyers back fast. Upcoming management talks are a short-term moment that could reset attention. Because the overall move is still fragile, buy in stages and keep each position size small.

Primary drivers

Analyst upgrades can bring new buyers and attention
Management presentations can shift investor focus quickly
Earnings from royalty deals lower the risk of single trial failure
Big selloff may reverse if selling pressure eases

How it played out

HALO: the target was not reached

Lyra published HALO on 2026-03-04 at 71.06 with expected growth of 18%. The thesis pointed to analyst upgrades, management presentations, royalty deal earnings, and the chance that a big selloff could reverse if selling pressure eased.

Inside the window from 2026-03-04 to 2026-06-02, HALO rose to a peak of 73.89 on 2026-05-12, a 4% gain. It stayed below the 83.84 target. The stock ended at 66.28. The thesis only partly played out: there was a bounce, but it was small and did not reach the published target.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All HALO signals